148 related articles for article (PubMed ID: 10352883)
1. Why transgenic and knockout animal models should be used (for drug efficacy studies in cancer).
Rosenberg MP; Bortner D
Cancer Metastasis Rev; 1998-1999; 17(3):295-9. PubMed ID: 10352883
[No Abstract] [Full Text] [Related]
2. [New approaches in experimental cancerology: in search of therapeutic models].
Guilbaud N; Kraus-Berthier L; Meyer-Losic F; Pierré A; Hickman J
Bull Cancer; 2001 Jan; 88(1):75-84. PubMed ID: 11182656
[No Abstract] [Full Text] [Related]
3. Developing new agents for the treatment of childhood cancer.
Kurmasheva R; Morton C; Houghton PJ
Curr Opin Investig Drugs; 2005 Dec; 6(12):1215-27. PubMed ID: 16372407
[TBL] [Abstract][Full Text] [Related]
4. Intellectual property. DuPont ups ante on use of Harvard's OncoMouse.
Marshall E
Science; 2002 May; 296(5571):1212. PubMed ID: 12016275
[No Abstract] [Full Text] [Related]
5. Medicine. Building better mouse models for studying cancer.
Marx J
Science; 2003 Mar; 299(5615):1972-5. PubMed ID: 12663895
[No Abstract] [Full Text] [Related]
6. Autophagy and cancer - insights from mouse models.
Mainz L; Rosenfeldt MT
FEBS J; 2018 Mar; 285(5):792-808. PubMed ID: 28921866
[TBL] [Abstract][Full Text] [Related]
7. The mighty mouse: genetically engineered mouse models in cancer drug development.
Sharpless NE; Depinho RA
Nat Rev Drug Discov; 2006 Sep; 5(9):741-54. PubMed ID: 16915232
[TBL] [Abstract][Full Text] [Related]
8. Current NCI preclinical antitumor screening in vivo: results of tumor panel screening, 1976-1982, and future directions.
Venditti JM; Wesley RA; Plowman J
Adv Pharmacol Chemother; 1984; 20():1-20. PubMed ID: 6398966
[No Abstract] [Full Text] [Related]
9. A prospective screening program: current screening and its status.
Goldin A; Venditti JM
Recent Results Cancer Res; 1981; 76():176-91. PubMed ID: 7232850
[No Abstract] [Full Text] [Related]
10. [Introduction of new screening system in National Cancer Institute].
Tsukagoshi S
Gan To Kagaku Ryoho; 1984 May; 11(5):1134-9. PubMed ID: 6539100
[No Abstract] [Full Text] [Related]
11. Are intellectual property rights hampering cancer research?
McBride G
J Natl Cancer Inst; 2004 Jan; 96(2):92-4. PubMed ID: 14734693
[No Abstract] [Full Text] [Related]
12. Current results of the screening program at the Division of Cancer Treatment, National Cancer Institute.
Goldin A; Venditti JM; Macdonald JS; Muggia FM; Henney JE; Devita VT
Eur J Cancer (1965); 1981 Feb; 17(2):129-42. PubMed ID: 6894902
[No Abstract] [Full Text] [Related]
13. Orthotopic models are necessary to predict therapy of transplantable tumors in mice.
Killion JJ; Radinsky R; Fidler IJ
Cancer Metastasis Rev; 1998-1999; 17(3):279-84. PubMed ID: 10352881
[TBL] [Abstract][Full Text] [Related]
14. Realistic rodents? Debate grows over new mouse models of cancer.
Garber K
J Natl Cancer Inst; 2006 Sep; 98(17):1176-8. PubMed ID: 16954466
[No Abstract] [Full Text] [Related]
15. Progress report on the screening program at the Division of Cancer Treatment, National Cancer Institute.
Goldin A; Venditti JM
Cancer Treat Rev; 1980 Dec; 7(4):167-76. PubMed ID: 7214373
[No Abstract] [Full Text] [Related]
16. [Antitumor drug screening at the National Cancer Institute, U.S.A].
Tsuruo T
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2809-15. PubMed ID: 3310904
[TBL] [Abstract][Full Text] [Related]
17. The National Cancer Institute's Natural Products Antineoplastic Development Program.
Douros J; Suffness M
Recent Results Cancer Res; 1980; 70():21-44. PubMed ID: 7355247
[TBL] [Abstract][Full Text] [Related]
18. The evolution of cancer chemotherapy.
Chabner BA
Hosp Pract (Off Ed); 1985 Apr; 20(4):115-9, 123-7. PubMed ID: 3932415
[No Abstract] [Full Text] [Related]
19. Overview of transgenic and gene knockout mice.
Yamamura K
Prog Exp Tumor Res; 1999; 35():13-24. PubMed ID: 10377748
[No Abstract] [Full Text] [Related]
20. Clinical development of anticancer agents--a National Cancer Institute perspective.
Marsoni S; Wittes R
Cancer Treat Rep; 1984 Jan; 68(1):77-85. PubMed ID: 6362870
[No Abstract] [Full Text] [Related]
[Next] [New Search]
